Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02164370 · ClinicalTrials.gov registry record
Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach
A clinical trial of Mild Pre-eclampsia and Severe Pre-eclampsia, sponsored by University of Washington.
- Completed
- Registry status
- 120
- Enrollment target
- 2
- Study locations
NCT02164370 is a study of Mild Pre-eclampsia and Severe Pre-eclampsia that has completed, run by University of Washington. The registered enrollment target is 120 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02164370, a study of Mild Pre-eclampsia and Severe Pre-eclampsia, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
Acid/base imbalances are not well understood in pre-eclamptics, and better tools are needed to allow a thorough and meaningful evaluation. Disorders of electrolytes and albumin are common findings \[13, 14\], and the impact of such disorders on acid-base homeostasis has increasingly been acknowledged \[4, 15\]. The purpose of this prospective case-control study is to evaluate acid-base status in 100 women with mild or severe pre-eclampsia and 25 healthy controls by applying the Stewart Fencl's physicochemical acid-base model. We hypothesize that several simultaneous, and possibly offsetting, metabolic acid-base disorders will be identified and quantified, and that these may be useful to guide clinicians in their medical management and indication for delivery. Intermediate and long-term goals are to evaluate the ability of the Stewart Fencl's physicochemical acid-base model to guide fluid management and predict maternal and neonatal outcomes.
Conditions Studied
Study Locations (2)
Washington
- University of Washington - Seattle
Western Cape
- University of Cape Town - Cape Town
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02164370
The ClinicalTrials.gov registry entry for NCT02164370 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Mild Pre-eclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT02164370 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Washington, Western Cape.
Frequently Asked Questions
What is clinical trial NCT02164370 about?
NCT02164370 is a clinical study titled "Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach". Acid/base imbalances are not well understood in pre-eclamptics, and better tools are needed to allow a thorough and meaningful evaluation. Disorders of electrolytes and albumin are common findings \[13, 14\], and the impact of such disorders on acid-base homeostasis has increasingly been acknowledge...
What is the current status of trial NCT02164370?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-10. Estimated completion is 2014-10.
What conditions does trial NCT02164370 study?
This clinical trial studies the following conditions: Mild Pre-eclampsia, Severe Pre-eclampsia.
Who is sponsoring clinical trial NCT02164370?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02164370 being conducted?
This trial has 2 study locations across Washington, Western Cape. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.